Chun D - Search Results

1

Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.

Corboz MR, Plaunt AJ, Malinin V, Li Z, Gauani H, Chun D, Cipolla D, Perkins WR, Chapman RW. Corboz MR, et al. Among authors: chun d. Eur J Pharmacol. 2022 Feb 5;916:174484. doi: 10.1016/j.ejphar.2021.174484. Epub 2021 Sep 9. Eur J Pharmacol. 2022. PMID: 34508752 Free article.

2

Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in rats.

Chapman RW, Li Z, Chun D, Gauani H, Malinin V, Plaunt AJ, Cipolla D, Perkins WR, Corboz MR. Chapman RW, et al. Among authors: chun d. Pulm Pharmacol Ther. 2021 Feb;66:101983. doi: 10.1016/j.pupt.2020.101983. Epub 2020 Dec 17. Pulm Pharmacol Ther. 2021. PMID: 33346142 Free article.

3

Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension.

Plaunt AJ, Islam S, Macaluso T, Gauani H, Baker T, Chun D, Viramontes V, Chang C, Corboz MR, Chapman RW, Li Z, Cipolla DC, Perkins WR, Malinin VS. Plaunt AJ, et al. Among authors: chun d. Int J Mol Sci. 2021 Jan 7;22(2):548. doi: 10.3390/ijms22020548. Int J Mol Sci. 2021. PMID: 33430435 Free PMC article.

4

Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.

Plaunt AJ, Rose SJ, Kang JY, Chen KJ, LaSala D, Heckler RP, Dorfman A, Smith BT, Chun D, Viramontes V, Macaluso A, Li Z, Zhou Y, Mark L, Basso J, Leifer FG, Corboz MR, Chapman RW, Cipolla D, Perkins WR, Malinin VS, Konicek DM. Plaunt AJ, et al. Among authors: chun d. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0031621. doi: 10.1128/AAC.00316-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33941518 Free PMC article.

5

Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections".

Plaunt AJ, Rose SJ, Kang JY, Chen KJ, LaSala D, Heckler RP, Dorfman A, Smith BT, Chun D, Viramontes V, Macaluso A, Li Z, Zhou Y, Mark L, Basso J, Leifer FG, Corboz MR, Chapman RW, Cipolla D, Perkins WR, Malinin VS, Konicek DM. Plaunt AJ, et al. Among authors: chun d. Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0125622. doi: 10.1128/aac.01256-22. Epub 2022 Oct 12. Antimicrob Agents Chemother. 2022. PMID: 36222535 Free PMC article. No abstract available.

6

Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Corboz MR, Plaunt AJ, Malinin VS, Li Z, Gauani H, Chun D, Cipolla D, Perkins WR, Chapman RW. Corboz MR, et al. Among authors: chun d. J Pharmacol Exp Ther. 2022 Oct;383(1):103-116. doi: 10.1124/jpet.122.001174. Epub 2022 Aug 31. J Pharmacol Exp Ther. 2022. PMID: 36507843

7

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.

Chen KJ, Zhang J, LaSala D, Basso J, Chun D, Zhou Y, McDonald PP, Perkins WR, Cipolla DC. Chen KJ, et al. Among authors: chun d. Front Immunol. 2023 Jun 27;14:1185727. doi: 10.3389/fimmu.2023.1185727. eCollection 2023. Front Immunol. 2023. PMID: 37441081 Free PMC article.

8

The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.

Basso J, Chen KJ, Zhou Y, Mark L, LaSala D, Dorfman A, Atalla M, Chun D, Viramontes V, Chang C, Leifer F, McDonald PP, Cipolla DC. Basso J, et al. Among authors: chun d. Front Pharmacol. 2023 Jul 19;14:1208780. doi: 10.3389/fphar.2023.1208780. eCollection 2023. Front Pharmacol. 2023. PMID: 37538173 Free PMC article.

9

Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection.

Konicek DM, Plaunt AJ, Gharse S, Rose SJ, Dorfman A, Sabnis A, Baker T, Gauani H, Chun D, Li Z, Perkins WR, Cipolla D, Malinin VS. Konicek DM, et al. Among authors: chun d. Pharmaceutics. 2023 Aug 31;15(9):2250. doi: 10.3390/pharmaceutics15092250. Pharmaceutics. 2023. PMID: 37765219 Free PMC article.

10

Total Joint Arthroplasty Is a Viable Treatment Option for Patients With Osteonecrosis and Osteoarthritis After Bone Marrow Transplantation.

Chang J, Chun DS, Wu CJ, Cochrane NH, Kim BI, Ryan SP, Seyler TM. Chang J, et al. Among authors: chun ds. Arthroplast Today. 2024 Apr 17;27:101373. doi: 10.1016/j.artd.2024.101373. eCollection 2024 Jun. Arthroplast Today. 2024. PMID: 38680846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

328 results

Search Page